Articles
Issues & Trends, Advocacy & Public Policy, Legislation and Legislative Advocacy, Risk Management, Supply chain management, Medical Device Regulation, Medical Device Safety
I&L Committee Topic: Ethylene Oxide (EtO) Sterilization
AHRMM Issues & Legislative (I&L) Committee identifies, reviews and follows the regulatory, environmental, quality of service and standards matters that impact the health care supply chain field. Each I&L Committee member closely monitors an important topic and compiles an update with useful information to help AHRMM members stay ahead of policy issues that affect their work and health care organization.
Analytics & Research, Cost Management, Cost, Quality and Outcomes (CQO) Movement, Regulations and Regulatory Advocacy, Performance Metrics
Value Based Purchasing Awareness Brief
This Awareness Brief provides a high level summary understanding of value based purchasing. The Hospital Value Based Purchasing (VBP) Program adjusts hospitals’ payments based on their performance in four domains that reflect hospital cost, quality and outcomes. This calendar year, 2016, is the Performance Measurement Period for the FY 2018 VBP Program.
Data Standards, Regulations and Regulatory Advocacy, Unique Device Identifier (UDI), Procurement
AHRMM Awareness Brief: Draft Guidance for UDI Convenience Kits
This Awareness Brief provides a quick reference to the Draft Guidance for UDI Convenience Kits, released by the FDA in January 2016. The draft guidance defines the term “convenience kit” for purposes of compliance with UDI labeling and data submission requirements only.
Capital Equipment, Clinical Resource Management (CRM), Products and Services Contracting, Cost Management, Physician Preference Items (PPI), Strategic Planning
AHRMM Leading Practice Statement on Supply Chain Integration
As a Leading Practice, the AHRMM Board of Directors adopts that Supply Chain Services be fully integrated into high cost clinical services departments.
Analytics & Research, Benchmarking, Cost Management, Reprocessing Medical Devices, Performance Metrics
AHRMM Statement on Comparative Effectiveness
AHRMM supports the concept and use of Comparative Effectiveness Research (CER) to provide evidence-based data to help inform purchasing decisions. CER is designed to support healthcare decisions by providing objective conclusions after comparing the effectiveness, benefits, and potential harm of various medical equipment, devices, or treatment options for specific episodes of care or states of disease.
By using objective data provided by CER, healthcare supply chain professionals have the ability to:
Capital Equipment, Change Management, Products and Services Contracting, Regulations and Regulatory Advocacy, Leadership
Alarm Safety Management
This learning lab covers alarm safety management in the health care supply chain field.
Benchmarking, Strategic Sourcing, Suppliers, Procurement
Statement on Pricing Transparency
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:
Cost, Quality and Outcomes (CQO) Movement, Logistics
UDI and Adverse Event Reporting Advisory
The Food and Drug Administration (FDA) UDI system is being phased in over several years. The first sunrise date (certain Class III devices) occurred 09/24/14. Recognizing UDI implementation will take time, healthcare supply chain and risk management professionals should be aware of already-implemented changes in the FDA’s adverse event reporting methodology. One of the changes required immediately is the use of the UDI in adverse event reporting.